Alaofi, A.L.; Shahid, M.; Raish, M.; Ansari, M.A.; Syed, R.; Kalam, M.A.
Identification of Doxorubicin as Repurposing Inhibitory Drug for MERS-CoV PLpro. Molecules 2022, 27, 7553.
https://doi.org/10.3390/molecules27217553
AMA Style
Alaofi AL, Shahid M, Raish M, Ansari MA, Syed R, Kalam MA.
Identification of Doxorubicin as Repurposing Inhibitory Drug for MERS-CoV PLpro. Molecules. 2022; 27(21):7553.
https://doi.org/10.3390/molecules27217553
Chicago/Turabian Style
Alaofi, Ahmed L., Mudassar Shahid, Mohammad Raish, Mushtaq Ahmad Ansari, Rabbani Syed, and Mohd Abul Kalam.
2022. "Identification of Doxorubicin as Repurposing Inhibitory Drug for MERS-CoV PLpro" Molecules 27, no. 21: 7553.
https://doi.org/10.3390/molecules27217553
APA Style
Alaofi, A. L., Shahid, M., Raish, M., Ansari, M. A., Syed, R., & Kalam, M. A.
(2022). Identification of Doxorubicin as Repurposing Inhibitory Drug for MERS-CoV PLpro. Molecules, 27(21), 7553.
https://doi.org/10.3390/molecules27217553